Literature DB >> 16574924

Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study.

Giulio Scigliano1, Massimo Musicco, Paola Soliveri, Immacolata Piccolo, Gabriele Ronchetti, Floriano Girotti.   

Abstract

BACKGROUND AND
PURPOSE: Sympathetic hyperactivity is a contributing cause of vascular disorders because it increases blood pressure, blood sugar, and blood lipids. Pervasive compromise of the central and peripheral autonomic nervous systems is common in idiopathic Parkinson disease (IPD) resulting in reduced sympathetic and parasympathetic function. We hypothesized that IPD was associated with reduced prevalence of cardiovascular disease risk factors as a result of reduced sympathetic activity.
METHODS: We performed a retrospective case-control study on 178 newly diagnosed consecutive IPD patients, and 533 age- (+/-3 years) and sex-matched controls with other neurological diseases seen over the same period at the same hospital. For each case and control the following were noted on admission: smoking, diabetes, hypertension, body mass index, serum glucose, plasma cholesterol, triglycerides and total lipid levels, and blood pressure.
RESULTS: Diabetes, history of smoking, high blood pressure, high blood glucose, high blood cholesterol, and triglycerides were significantly less frequent in IPD than controls.
CONCLUSIONS: IDP is a natural model of impaired hypothalamic-pituitary-adrenal axis activity and generalized sympathetic denervation. We interpret the association of untreated IPD with reduced vascular diseases risk factors as attributable to reduced autonomic activity, suggesting that autonomic hyperactivity may be involved in the pathogenesis of vascular disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574924     DOI: 10.1161/01.STR.0000217384.03237.9c

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  72 in total

1.  The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease.

Authors:  Gurdeep Marwarha; Turk Rhen; Trevor Schommer; Othman Ghribi
Journal:  J Neurochem       Date:  2011-10-24       Impact factor: 5.372

Review 2.  How might physical activity benefit patients with Parkinson disease?

Authors:  Arlène D Speelman; Bart P van de Warrenburg; Marlies van Nimwegen; Giselle M Petzinger; Marten Munneke; Bastiaan R Bloem
Journal:  Nat Rev Neurol       Date:  2011-07-12       Impact factor: 42.937

3.  Non-genetic factors associated with the risk of Parkinson's disease in Iranian patients.

Authors:  N Hosseini Tabatabaei; B Babakhani; A Hosseini Tabatabaei; Z Vahabi; A Soltanzadeh
Journal:  Funct Neurol       Date:  2013 Apr-May

4.  Dietary fats, cholesterol and iron as risk factors for Parkinson's disease.

Authors:  Karen M Powers; Terri Smith-Weller; Gary M Franklin; W T Longstreth; Phillip D Swanson; Harvey Checkoway
Journal:  Parkinsonism Relat Disord       Date:  2008-04-18       Impact factor: 4.891

5.  Correlation between biochemical indicators of blood lipid with cerebral vascular diseases.

Authors:  Dongmei Wang; Jun Hu; Qiao Ma; Jiarui Ma; Binjian Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

6.  Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study.

Authors:  Xuemei Huang; Alvaro Alonso; Xuguang Guo; David M Umbach; Maya L Lichtenstein; Christie M Ballantyne; Richard B Mailman; Thomas H Mosley; Honglei Chen
Journal:  Mov Disord       Date:  2015-01-14       Impact factor: 10.338

7.  Understanding the links between cardiovascular disease and Parkinson's disease.

Authors:  Judy Potashkin; Xuemei Huang; Claudia Becker; Honglei Chen; Thomas Foltynie; Connie Marras
Journal:  Mov Disord       Date:  2019-09-04       Impact factor: 10.338

8.  Reduced striatal tyrosine hydroxylase in incidental Lewy body disease.

Authors:  Thomas Gerald Beach; Charles H Adler; Lucia I Sue; Jeffrey B Peirce; Jyothi Bachalakuri; Jessica E Dalsing-Hernandez; Lih Fen Lue; John N Caviness; Donald J Connor; Marwan N Sabbagh; Douglas G Walker
Journal:  Acta Neuropathol       Date:  2007-11-06       Impact factor: 17.088

9.  Diet and age interactions with regards to cholesterol regulation and brain pathogenesis.

Authors:  Romina M Uranga; Jeffrey N Keller
Journal:  Curr Gerontol Geriatr Res       Date:  2010-04-11

10.  Reply: Plasma cholesterol and Parkinson's disease: Is the puzzle only apparent?

Authors:  Xuemei Huang; Honglei Chen; Helen Petrovitch; Richard Mailman; Webster Ross
Journal:  Mov Disord       Date:  2010-01-15       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.